A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia
NCT04031742 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2023-08-09
Summary
A study to evaluate safety and efficacy of IBI306 in subjects with homozygous familial hypercholesterolemia.
Conditions
- Homozygous Familial Hypercholesterolemia
Interventions
- BIOLOGICAL
-
IBI306
Administered by subcutaneous injection
- BIOLOGICAL
-
IBI306
Administered by subcutaneous injection
Sponsors & Collaborators
-
Innovent Biologics (Suzhou) Co. Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-29
- Primary Completion
- 2021-12-30
- Completion
- 2021-12-30
Countries
- China
Study Locations
More Related Trials
-
A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT06816264 ·Status: COMPLETED ·Phase: PHASE2
-
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
NCT01813422 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
NCT04338165 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia
NCT03403374 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina
NCT04306237 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)
NCT01258907 ·Status: COMPLETED ·Phase: PHASE2
-
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
NCT00384293 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
NCT00185042 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
NCT06691217 ·Status: RECRUITING ·Phase: PHASE2
-
Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention
NCT04999293 ·Status: COMPLETED
-
Integrated Biomarker And Imaging Study - 2
NCT00268996 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease
NCT02601560 ·Status: COMPLETED ·Phase: PHASE2
-
PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis
NCT07119918 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
NCT01975376 ·Status: TERMINATED ·Phase: PHASE3
-
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
NCT06902740 ·Status: RECRUITING ·Phase: PHASE4
-
Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
NCT05549336 ·Status: UNKNOWN
-
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
NCT06572267 ·Status: RECRUITING ·Phase: PHASE2
-
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
NCT00733174 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound
NCT06586684 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers
NCT04045769 ·Status: COMPLETED ·Phase: PHASE1
-
Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS)
NCT05741086 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism
NCT03773172 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State
NCT03086356 ·Status: COMPLETED ·Phase: PHASE1
-
Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)
NCT04826172 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
NCT05975554 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA